Question 1

How big is the Global Precision Oncology market?

Accepted Answer

According to Value Market Research, the global Global Precision Oncology market size was estimated at USD 139.89 Billion in 2025 and is expected to reach USD 151.32 Billion in 2026.

Question 2

What is the Global Precision Oncology market growth?

Accepted Answer

The global Global Precision Oncology market is expected to grow at a CAGR of 8.17% from 2026-2034 to reach USD 283.63 Billion by 2034.

Question 3

Which region holds the highest share in the Global Precision Oncology market?

Accepted Answer

North America held the highest share in the global Global Precision Oncology market.

Question 4

How is the Global Precision Oncology market segmented in the report?

Accepted Answer

The Global Precision Oncology market is segmented By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, Others), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies).

Question 5

Which segment accounted for the largest precision oncology market share?

Accepted Answer

The therapeutics segment dominated the market with a share of 59.38% in 2025, supported by increasing approvals of targeted therapies, expanding biomarker-based treatment strategies, and growing clinical adoption of personalized oncology medicines.

Question 6

What are the factors driving the precision oncology market?

Accepted Answer

Key drivers include the increasing global cancer burden, wider adoption of genomic sequencing, expanding biomarker-guided therapies, rising precision medicine initiatives, supportive regulatory approvals, and continuous advancements in molecular diagnostics and artificial intelligence that improve personalized cancer treatment outcomes.

Question 7

Who are the key players in the Global Precision Oncology market?

Accepted Answer

Some key players include Acrivon Therapeutics Inc., AstraZeneca plc, Caris Life Sciences, Exact Sciences Corporation and F. Hoffmann-La Roche Ltd.

Global Precision Oncology Market Size, Share, Trends & Growth Analysis Report Segmented By Product Type (Diagnostics, Therapeutics), Cancer Type, End-use and Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2026-2034